CNR1 anticorps (AA 150-200)
Aperçu rapide pour CNR1 anticorps (AA 150-200) (ABIN5540252)
Antigène
Voir toutes CNR1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 150-200
-
Specificité
- This antibody detects endogenous levels of Cannabinoid receptor 1 (region surrounding Phe189).
-
Purification
- Affinity Chromatography
-
Immunogène
- Synthetic peptide corresponding to amino acids 150-200 of Human CB1.
-
-
-
-
Indications d'application
- Western blot : 1/500-1/1000. Immunohistochemistry on Paraffin sections : 1/50-1/200.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 95 % by SDS-PAGE) Aff - Purified
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
-
Date de péremption
- 12 months
-
-
- CNR1 (Cannabinoid Receptor 1 (CNR1))
-
Autre désignation
- cannabinoid receptor 1
-
Sujet
- The cannabinoid receptors (CB1 and CB2) are G protein-coupled receptors that inhibit adenylate cyclase activity in response to psychoactive cannabinoids. CB1 is expressed in brain tissue and, in low levels, in testis. CB2 is expressed only by cells of the immune system. The cannabinoid receptors mediate most of the cannabinoid-induced responses in a dose-dependent, stereoselective manner. This response system is thought to be involved in specific brain functions, such as nociception, control of movement, memory and neuroendocrine regulation, as well as having a possible role in brain development. In addition, CB1 may mediate the addictive behavior involved with the use of psychoactive cannabinoids, such as THC in marijuana.
-
UniProt
- P21554
-
Pathways
- Feeding Behaviour
Antigène
-